Presentation

You are about to review presentations, reports and/or filings of Telomir Pharmaceuticals, Inc., that contain time-sensitive information. The information contained therein is only accurate as of the date thereof. Telomir Pharmaceuticals, Inc. will not be reviewing or updating the material that is contained in these items after the date thereof. The information contained therein may be updated, amended, supplemented or otherwise altered by subsequent presentations, reports and/or filings by Telomir Pharmaceuticals, Inc.

I Accept I Decline

Reports Regarding LMP Automotive Holdings’ Accounting or Auditing Matters or Other Concerns and Communications with the Board of Directors.

Shareholders and interested parties may communicate directly with the Board of Directors, the Audit Committee of the Board of Directors with respect to accounting issues, questionable accounting or auditing matters or internal accounting controls, any other Board committee, any individual Director, any group of Directors or the Lead Independent Director by e-mailing [email protected].

Reports may be made anonymously or confidentially.